$1.06 0.04 (+3.92%)
11/25/2009 3:59 PM

Aeterna Zentaris, Inc. (USA) (AEZS)

CAPS Rating: 5 out of 5

A growing global biopharmaceutical company focused on endrocrine therapy and oncology, in drug discovery, development and commercialization.

Featured Broker Partners